Prognostic implications of residual cancer burden (RCB) index for adjuvant capecitabine survival benefit in patients with triple-negative breast cancer

First Author / 第一作者

Sae Byul Lee

Institution / 單位

Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center

Audio / 音訊檔

Author Group / 作者群

Soo-Young Lee

Author Group Institution/ 作者群單位

Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center

Category / 主題分類

Clinical Research

Keyword / 關鍵字

residual cancer burden, NAC, capecitabine

Back to list